Clinical trials
Active, not recruiting Phase 2 Burkitt Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2009 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| Children's Oncology Group | 1 |
| City of Hope Medical Center | 1 |
| Cothera Bioscience, Inc | 1 |
| Fred Hutchinson Cancer Center | 1 |
| M.D. Anderson Cancer Center | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Burkitt Lymphoma | 17 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Lymphoma, B-Cell | 3 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Recurrence | 3 |
| Anemia, Refractory, with Excess of Blasts | 2 |
| Dendritic Cell Sarcoma, Interdigitating | 2 |
| Hodgkin Disease | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Lymphoma, B-Cell, Marginal Zone | 2 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.